Table 1. Single (unpaired) samples used in IgG subclass comparisons, and clinical status of the Indian and Sudanese patient groups.
VL patient status | Controls | |||||||
Unpaired group | Active | Cured | Relapsed | Treateda | PKDL | Other diseases | EHC (seropositive) | EHC (seronegative) |
Trial 1 India | 20 | 21 | 19 | - | - | 20 | - | 20 |
Trial 2 (Expanded) India | 46 | 28 | 35 | - | 24 | 28 | 28 | 32 |
Trial Sudan | 47 | - | - | 22 | 23 | - | 30 | 12 |
EHC = endemic healthy control; PKDL = post kala-azar dermal leishmaniasis.
treated, not in recent past, but time of treatment unknown.